Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

In vitro Controlled Release of two new Tuberculocidal Adamantane Aminoethers from Solid Pharmaceutical Formulations (II).

Vlachou M, Siamidi A, Spaneas D, Lentzos D, Ladia P, Anastasiou K, Papanastasiou I, Foscolos AS, Georgiadis MO, Karalis V, Kellici T, Mavromoustakos T.

Drug Res (Stuttg). 2017 Jul 19. doi: 10.1055/s-0043-114012. [Epub ahead of print]

PMID:
28724167
2.

In vitro Controlled Release from Solid Pharmaceutical Formulations of two new Adamantane Aminoethers with Antitubercular Activity (I).

Vlachou M, Siamidi A, Diamantidi E, Iliopoulou A, Papanastasiou I, Ioannidou V, Kourbeli V, Foscolos AS, Vocat A, Cole ST, Karalis V, Kellici T, Mavromoustakos T.

Drug Res (Stuttg). 2017 May 30. doi: 10.1055/s-0042-121491. [Epub ahead of print]

PMID:
28561241
3.

Paradoxical bradycardia and blood pressure elevation during dobutamine stress echocardiography reveal ischemia in a patient with syncope.

Kamperidis V, Giannakoulas G, Vlachou M, Ntourtsiou S, Sianos G, Karvounis H.

Hellenic J Cardiol. 2016 Nov 17. pii: S1109-9666(16)30183-X. doi: 10.1016/j.hjc.2016.11.025. [Epub ahead of print] No abstract available.

4.

Sensory migraine aura is not associated with structural grey matter abnormalities.

Hougaard A, Amin FM, Arngrim N, Vlachou M, Larsen VA, Larsson HB, Ashina M.

Neuroimage Clin. 2016 Feb 17;11:322-7. doi: 10.1016/j.nicl.2016.02.007. eCollection 2016.

5.

Neutron diffraction and multinuclear solid state NMR investigation into the structures of oxide ion conducting La9.6Si6O26.4 and La8Sr2Si6O26, and their hydrated phases.

Corrie BJ, Shin JF, Hull S, Knight KS, Vlachou MC, Hanna JV, Slater PR.

Dalton Trans. 2016 Jan 7;45(1):121-33. doi: 10.1039/c5dt03190g.

PMID:
26575496
6.

The Cost Burden of Monoclonal Antibody Therapy In An Athens Greece Tertiary Hospital. A Seven Year Cost Comparison Analysis.

Papandreou V, Chatzidimitriou G, Vlachou M, Stathopoulou P, Papadopoulou V.

Value Health. 2015 Nov;18(7):A640. doi: 10.1016/j.jval.2015.09.2282. Epub 2015 Oct 20. No abstract available.

7.

Comparative evaluation of xenobiotics in human and dietary milk: persistent organic pollutants and mycotoxins.

Tsakiris IN, Kokkinakis E, Dumanov JM, Tzatzarakis MN, Flouris AD, Vlachou M, Tsatsakis AM.

Cell Mol Biol (Noisy-le-grand). 2013 Nov 3;59(1):58-66. Review.

PMID:
24200021
8.

Peripheral blood lymphocyte recovery and overall survival in pediatric acute lymphoblastic leukemia.

Hatzipantelis E, Pana ZD, Vlachou M, Papageorgiou T, Tragiannidis A, Athanassiadou F.

Pediatr Blood Cancer. 2014 Jan;61(1):181-3. doi: 10.1002/pbc.24736. Epub 2013 Aug 30. No abstract available.

PMID:
24039040
9.

Results of the two incidence screenings in the National Lung Screening Trial.

Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, Clingan KL, Duan F, Fagerstrom RM, Gareen IF, Gatsonis CA, Gierada DS, Jain A, Jones GC, Mahon I, Marcus PM, Rathmell JM, Sicks J; National Lung Screening Trial Research Team.

N Engl J Med. 2013 Sep 5;369(10):920-31. doi: 10.1056/NEJMoa1208962.

10.

Risk assessment scenarios of children's exposure to aflatoxin M1 residues in different milk types from the Greek market.

Tsakiris IN, Tzatzarakis MN, Alegakis AK, Vlachou MI, Renieri EA, Tsatsakis AM.

Food Chem Toxicol. 2013 Jun;56:261-5. doi: 10.1016/j.fct.2013.02.024. Epub 2013 Feb 21.

PMID:
23439481
11.

Ιnflammatory or septic arthritis associated with mycoplasma pneumonia in children: Two case reports and review of the literature.

Vlachou M, Dialyna P, Bartsocas C, Dimitriadis D.

Eur J Orthop Surg Traumatol. 2012 Dec;22(8):721-6. doi: 10.1007/s00590-011-0894-7. Epub 2011 Oct 21.

PMID:
27526077
12.

Conformational analysis of two novel cytotoxic C2-substituted pyrrolo[2,3-f]quinolines in aqueous media, organic solvents, membrane bilayers and at the putative active site.

Varvarigou N, Megariotis G, Leonis G, Vrontaki E, Maniati AM, Vlachou M, Eikosipentaki A, Kompogennitaki R, Papadopoulos MG, Grdadolnik SG, Komiotis D, Mavromoustakos T, Tsotinis A.

Bioorg Med Chem. 2012 Nov 1;20(21):6276-84. doi: 10.1016/j.bmc.2012.09.012. Epub 2012 Sep 15.

PMID:
23040892
13.

Strategies to work with HLA data in human populations for histocompatibility, clinical transplantation, epidemiology and population genetics: HLA-NET methodological recommendations.

Sanchez-Mazas A, Vidan-Jeras B, Nunes JM, Fischer G, Little AM, Bekmane U, Buhler S, Buus S, Claas FH, Dormoy A, Dubois V, Eglite E, Eliaou JF, Gonzalez-Galarza F, Grubic Z, Ivanova M, Lie B, Ligeiro D, Lokki ML, da Silva BM, Martorell J, Mendonça D, Middleton D, Voniatis DP, Papasteriades C, Poli F, Riccio ME, Vlachou MS, Sulcebe G, Tonks S, Nevessignsky MT, Vangenot C, van Walraven AM, Tiercy JM.

Int J Immunogenet. 2012 Dec;39(6):459-72; quiz 473-6. doi: 10.1111/j.1744-313X.2012.01113.x. Epub 2012 Apr 26.

14.

Reduced lung-cancer mortality with low-dose computed tomographic screening.

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD.

N Engl J Med. 2011 Aug 4;365(5):395-409. doi: 10.1056/NEJMoa1102873. Epub 2011 Jun 29.

15.

Treatment of severe thoracolumbar kyphoscoliosis on the ground of ganglioneuroblastoma of the diaphragm: a case report.

Vlachou M, Verikokakis A, Grivas T, Dimitriadis D.

J Pediatr Orthop B. 2012 Mar;21(2):155-9. doi: 10.1097/BPB.0b013e32834742af.

PMID:
21527857
16.

Split tendon transfers for the correction of spastic varus foot deformity: a case series study.

Vlachou M, Dimitriadis D.

J Foot Ankle Res. 2010 Dec 14;3:28. doi: 10.1186/1757-1146-3-28.

17.

Split tibialis posterior tendon transfer for correction of spastic equinovarus hindfoot deformity.

Vlachou M, Beris A, Dimitriadis D.

Acta Orthop Belg. 2010 Oct;76(5):651-7.

PMID:
21138221
18.

Haemolymphangiomas of the lower extremities: two case reports and review of the literature.

Vlachou M, Kosmidis E, Filiopoulos K.

J Pediatr Orthop B. 2011 Mar;20(2):105-10. doi: 10.1097/BPB.0b013e328341dfd1. Review.

PMID:
21116192
19.

The National Lung Screening Trial: overview and study design.

National Lung Screening Trial Research Team, Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, Galen B, Gareen IF, Gatsonis C, Goldin J, Gohagan JK, Hillman B, Jaffe C, Kramer BS, Lynch D, Marcus PM, Schnall M, Sullivan DC, Sullivan D, Zylak CJ.

Radiology. 2011 Jan;258(1):243-53. doi: 10.1148/radiol.10091808. Epub 2010 Nov 2.

20.

Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis.

Argyriou AA, Karanasios P, Makridou A, Vlachou M, Giannakopoulou F, Makris N.

Neurodegener Dis. 2011;8(3):146-8. doi: 10.1159/000318084. Epub 2010 Aug 13.

PMID:
20714119

Supplemental Content

Loading ...
Support Center